Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.
Rare diseases affect roughly 30 million Americans, yet only 5 percent of the estimated 7,000 known rare diseases have cures or treatments approved by the FDA. Each February, clinical, tech, and advocacy communities around the world pause to reflect on this fact and take time to recognize the strides we’ve made and what is to […]
Face2Gene Patient Matching aims to use de-identified facial patterns and other clinical data in your case to find phenotypic similarities to other cases in Face2Gene. We will periodically scan all cases submitted to Patient Matching. If a potential match is found, you and the other clinician(s) who submitted the matching cases will be informed. If […]
DID YOU KNOW: By adding clinical features to your cases in Face2Gene, you increase the possible syndrome matches to 7,000+. NEW: Include features in each of your cases by automatically extracting HPO terms from clinical notes. How It Works 1) Copy your clinical notes to your case in Face2Gene CLINIC 2) Click the ‘Extract’ button to review the HPO* […]
FDNA’s Face2Gene technology is now being used by more than 70% of clinical geneticists at over 2,000 institutions in 130 countries. It was an exciting 2018 for FDNA, as we continued on our path to bring AI-based phenotyping technologies to clinicians, researchers, and labs globally. Take a look below for a recap of what the FDNA team […]
Personalizing Medicine with Artificial Intelligence and Facial Analysis Presented by Omar Abdul-Rahman, MD, University of Nebraska Medical Center Precision Medicine World Conference (PMWC)| September 24-25, 2018 | Duke University This post is based on a presentation given at PMWC Duke. Watch the full presentation here. At the Precision Medicine World Conference (PMWC) Duke meeting, Dr. […]
FDNA and Microsoft Genomics are working together to integrate the most advanced Artificial Intelligence solutions to support clinical genomics. Combining next-generation phenotyping (NGP), with next-generation sequencing (NGS) enables today’s health and life science organizations to reach more thorough, accurate, and actionable results and improve healthcare outcomes. Microsoft Genomics and FDNA are empowering stakeholders to use […]
San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Annual Meeting, October 16-20 in San Diego and tell you more about how Face2Gene facilitates the sharing of phenotypic information with labs for improved NGS analysis. To learn more, attend our exhibitor education event, swing […]
Change in healthcare comes in many forms. Some say it’s legislature. Some say it’s technology. Some will cite time and patience–but those with an inside view on rare disease advocacy know that the driving force behind change usually comes in the shape of a mother who has just been told her child’s life will never […]
ThinkGenetic recently hosted a panel discussion among researchers involved in the Genomics Collaborative, an FDNA initiative connecting researchers, clinicians, patients, laboratories, and advocacy groups to further disease discovery. Panel members presented their work with the collaborative, followed by a Q&A session moderated by Dawn Laney, all of which is available to watch at the bottom […]